{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:07:07Z","timestamp":1788264427537,"version":"build-2803163510"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The tumor immune microenvironment (TIME) and N\n                      <jats:sup>7<\/jats:sup>\n                      -methylguanosine (m7G) modification play crucial roles in the progression of acute myeloid leukemia (AML). This study aims to establish an IME-related and m7G-related prognostic model for improved risk stratification and personalized treatment in AML.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Immune score for the Cancer Genome Atlas acute myeloid leukemia (AML) patients were calculated using the ESTIMATE algorithm, followed by identification of immune score-associated differentially expressed genes Non-negative matrix factorization (NMF) clustering was performed to stratify AML subtypes based on immune microenvironment (immune microenvironment)-related DEGs and 29 m7G regulatory genes. Intersecting DEGs co-linked to IME and m7G features were analyzed through weighted gene co-expression network analysis Weighted correlation network analysis combined with univariate Cox, LASSO, and multivariate Cox regression to establish a prognostic signature. Biological pathway disparities between risk subgroups were analyzed via Gene Set Enrichment Analysis, Gene Set Variation Analysis, and ssGSEA. A clinical nomogram integrating the signature with prognostic indicators was developed. The expression of the 12 prognostic genes were tested and compared in AML and healthy donors. Drug sensitivity predictions for high-risk patients were generated using oncoPredict, supported by molecular docking simulations of ligand-target interactions and\n                      <jats:italic>in vitro<\/jats:italic>\n                      validation of candidate compounds in AML cell models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We constructed an IMEm7G prognostic signature comprising 12 genes (MPZL3, TREML2, PTP4A3, AHCYL1, CBR1, REEP5, PPM1H, WDFY3, LAMC3, KCTD1, DDIT4, KBTBD8) that robustly stratified AML risk and predicted survival in multiple cohorts. The high- and low-risk subgroups exhibited divergent biological pathways, mutational landscapes, immune infiltration patterns, immune checkpoint expression, and HLA profiles. This signature further guided therapeutic selection, with dactolisib identified as a high-risk-specific candidate. The quantitative real-time PCR (qPCR) analysis demonstrated that in comparison with healthy donors, the expression of WDFY3, PPM1H, and REEP5 was significantly lower, while that of PTP4A3, AHCYL1, CBR1, MPZL3, TREML2, and KBTBD8 was higher in AML patients.\n                      <jats:italic>In vitro<\/jats:italic>\n                      CCK-8 assays validated dactolisib\u2019s monotherapy efficacy and synergistic cytotoxicity when combined with doxorubicin in AML cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The IMEm7G gene signature established in our study effectively optimized the risk classification and predicted immunotherapy response in AML. Moreover, dactolisib was identified and demonstrated cytostatic activity alone and synergistic effects with doxorubicin in AML cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2025.1540992","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T01:51:32Z","timestamp":1749779492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The joint role of the immune microenvironment and N7-methylguanosine for prognosis prediction and targeted therapy in acute myeloid leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhixiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongbin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.devcel.2015.10.023","article-title":"Network analysis identifies mitochondrial regulation of epidermal differentiation by MPZL3 and FDXR","volume":"35","author":"Bhaduri","year":"2015","journal-title":"Dev. Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2105-13-S4-S2","article-title":"PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL","volume":"13","author":"Bramucci","year":"2012","journal-title":"BMC Bioinforma."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"B4","first-page":"1640","article-title":"N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer","volume":"13","author":"Cai","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12032-023-02239-8","article-title":"Synergistic anti-proliferative and apoptotic effect of NVP-BEZ235 and curcumin on human SH-SY5Y neuroblastoma cells","volume":"41","author":"\u00c7etin","year":"2023","journal-title":"Med. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.62347\/LYDF1241","article-title":"Identification of new microtubule small-molecule inhibitors and microtubule-associated genes against triple negative breast cancer","volume":"14","author":"Chen","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/ajh.26309","article-title":"A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia","volume":"96","author":"Chen","year":"2021","journal-title":"Am. J. Hematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41419-023-06171-7","article-title":"PI3K\/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer","volume":"14","author":"Deng","year":"2023","journal-title":"Cell Death Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"DE Simone","year":"2015","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1080\/15548627.2020.1822628","article-title":"The role of autophagy in targeted therapy for acute myeloid leukemia","volume":"17","author":"DU","year":"2021","journal-title":"Autophagy"},{"key":"B100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41698-024-00643-5","article-title":"Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials","volume":"8","author":"Elsayed","year":"2024","journal-title":"NPJ Precis. Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood.2020008211","article-title":"How I diagnose and treat NPM1-mutated AML","volume":"137","author":"Falini","year":"2021","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"106477","DOI":"10.1016\/j.phrs.2022.106477","article-title":"The REEP family of proteins: molecular targets and role in pathophysiology","volume":"185","author":"Fan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"B15","doi-asserted-by":"publisher","first-page":"695865","DOI":"10.3389\/fimmu.2021.695865","article-title":"Prognosis and characterization of immune microenvironment in acute myeloid leukemia through identification of an autophagy-related signature","volume":"12","author":"Fu","year":"2021","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1093\/bioinformatics\/bti653","article-title":"Improving molecular cancer class discovery through sparse non-negative matrix factorization","volume":"21","author":"Gao","year":"2005","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-985x.2010.00676_9.x","article-title":"ggplot2: elegant graphics for data analysis","volume":"174","author":"Ginestet","year":"2011","journal-title":"J. R. Stat. Soc. Ser. A Statistics Soc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.21147\/j.issn.1000-9604.2021.05.08","article-title":"Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma","volume":"33","author":"Gui","year":"2021","journal-title":"Chin. J. Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1456392","DOI":"10.3389\/fimmu.2024.1456392","article-title":"Exploring the transcriptomic landscape of moyamoya disease and systemic lupus erythematosus: insights into crosstalk genes and immune relationships","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nm.4210","article-title":"DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling","volume":"22","author":"Guryanova","year":"2016","journal-title":"Nat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.7150\/ijbs.90382","article-title":"M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets","volume":"20","author":"Han","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e153470","DOI":"10.1172\/JCI153470","article-title":"Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47","volume":"133","author":"Hu","year":"2023","journal-title":"J. Clin. Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2147\/IJN.S290731","article-title":"Synergistic inhibition of drug-resistant Colon cancer growth with PI3K\/mTOR dual inhibitor BEZ235 and nano-emulsioned paclitaxel via reducing multidrug resistance and promoting apoptosis","volume":"16","author":"Hu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/s12276-024-01316-w","article-title":"YAP promotes global mRNA translation to fuel oncogenic growth despite starvation","volume":"56","author":"Hwang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"W488-W493","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.omtn.2023.08.008","article-title":"Unveiling ATF6 and PPM1H signaling in hepatocellular carcinoma progression: from ER stress to tumor suppression","volume":"33","author":"Iyer","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1158\/0008-5472.CAN-12-1110","article-title":"Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide","volume":"72","author":"Jang","year":"2012","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1258\/ebm.2012.011433","article-title":"Paradoxical expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women","volume":"237","author":"Jeong","year":"2012","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"108114","DOI":"10.1016\/j.pharmthera.2022.108114","article-title":"Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy","volume":"235","author":"Joshi","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1002\/cncr.30203","article-title":"TP53 mutations in newly diagnosed acute myeloid leukemia: clinicomolecular characteristics, response to therapy, and outcomes","volume":"122","author":"Kadia","year":"2016","journal-title":"Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinforma."},{"key":"B36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2159-8290.CD-11-0062","article-title":"PPM1H is a p27 phosphatase implicated in trastuzumab resistance","volume":"1","author":"Lee-Hoeflich","year":"2011","journal-title":"Cancer Discov."},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/path.5492","article-title":"Anti-tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma","volume":"252","author":"Leung","year":"2020","journal-title":"J. Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2406686121","DOI":"10.1073\/pnas.2406686121","article-title":"KCTD1 regulation of Adenylyl cyclase type 5 adjusts striatal cAMP signaling","volume":"121","author":"Liao","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"781623","DOI":"10.3389\/fphar.2021.781623","article-title":"NVP-BEZ235 inhibits renal cell carcinoma by targeting TAK1 and PI3K\/Akt\/mTOR pathways","volume":"12","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2020.02.011","article-title":"Remodeling tumor immune microenvironment via targeted blockade of PI3K-\u03b3 and CSF-1\/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy","volume":"321","author":"Li","year":"2020","journal-title":"J. Control Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1021\/acs.nanolett.1c01469","article-title":"Supramolecular antagonists promote mitochondrial dysfunction","volume":"21","author":"Li","year":"","journal-title":"Nano Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.3390\/ijms20215347","article-title":"PD-L1\/PD-1 Axis in glioblastoma Multiforme","volume":"20","author":"Litak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"113192","DOI":"10.1016\/j.yexcr.2022.113192","article-title":"Targeting PI3K\/AKT\/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax","volume":"417","author":"Liu","year":"2022","journal-title":"Exp. Cell Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1200\/JCO.2012.44.3184","article-title":"Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study","volume":"31","author":"Li","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3389\/fimmu.2020.01685","article-title":"HLA-G neo-expression on tumors","volume":"11","author":"Loustau","year":"2020","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform"},{"key":"B50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA a Cancer J. For Clin."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.21873\/anticanres.13569","article-title":"Low IRBIT levels are associated with chemo-resistance in gastric cancer patients","volume":"39","author":"Nakazawa","year":"2019","journal-title":"Anticancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"eadi2952","DOI":"10.1126\/scitranslmed.adi2952","article-title":"Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis","volume":"16","author":"Neo","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"984","DOI":"10.6004\/jnccn.2012.0103","article-title":"NCCN clinical practice guidelines acute myeloid leukemia","volume":"10","author":"O'Donnell","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1182\/blood.v58.6.1203.bloodjournal5861203","article-title":"Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B","volume":"58","author":"Rai","year":"1981","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","article-title":"Current status and future perspectives in targeted therapy of NPM1-mutated AML","volume":"36","author":"Ranieri","year":"2022","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1541-7786.MCR-17-0338","article-title":"Adipocytes sequester and metabolize the chemotherapeutic daunorubicin","volume":"15","author":"Sheng","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1038\/s41467-022-35604-8","article-title":"A genome-wide CRISPR screen identifies WDFY3 as a regulator of macrophage efferocytosis","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov., Adv. Treat. Acute Myeloid Leukemia New Drugs New Challenges"},{"key":"B62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00018-022-04149-w","article-title":"Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells","volume":"79","author":"Stern","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B64","doi-asserted-by":"publisher","first-page":"111211","DOI":"10.1016\/j.intimp.2023.111211","article-title":"Combination therapy of acute myeloid leukemia by dual PI3K\/mTOR inhibitor BEZ235 and TLR-7\/8 agonist R848 in murine model","volume":"125","author":"Taghiloo","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","article-title":"Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Tallman","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"B66","doi-asserted-by":"publisher","first-page":"W556-W560","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/neuonc\/noab159","article-title":"The PI3K\/Akt\/mTOR pathway as a preventive target in melanoma brain metastasis","volume":"24","author":"Tehranian","year":"2022","journal-title":"Neuro Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","article-title":"MDSC; the most important cell you have never heard of","volume":"40","author":"Tesi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.3390\/ijms19124080","article-title":"7-Methylguanosine modifications in transfer RNA (tRNA)","volume":"19","author":"Tomikawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s43018-021-00212-w","article-title":"Epigenetic achilles' heel of AML","volume":"2","author":"Ueda","year":"2021","journal-title":"Nat. Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1182\/bloodadvances.2020002512","article-title":"TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML","volume":"4","author":"Vadakekolathu","year":"2020","journal-title":"Blood Adv."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J. Clin. Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1038\/s41375-020-0895-9","article-title":"Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia","volume":"34","author":"Wander","year":"2020","journal-title":"Leukemia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/1673-5374.346468","article-title":"The Alzheimer's disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation","volume":"18","author":"Wang","year":"","journal-title":"Neural Regen. Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e007253","DOI":"10.1136\/jitc-2023-007253","article-title":"Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response","volume":"11","author":"Wang","year":"","journal-title":"J. Immunother. Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12967-024-04938-w","article-title":"Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature14978","article-title":"Cell-fate determination by ubiquitin-dependent regulation of translation","volume":"525","author":"Werner","year":"2015","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/14728222.2022.2049756","article-title":"Targeting mitochondria in dermatological therapy: beyond oxidative damage and skin aging","volume":"26","author":"Wikramanayake","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"B81","first-page":"6698","article-title":"Candidate genes for cross-resistance against DNA-damaging drugs","volume":"62","author":"Wittig","year":"2002","journal-title":"Cancer Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41416-019-0450-5","article-title":"Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts","volume":"120","author":"Xu","year":"2019","journal-title":"Br. J. Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41408-024-01103-w","article-title":"Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia","volume":"14","author":"Yao","year":"2024","journal-title":"Blood Cancer J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/cm9.0000000000003073","article-title":"Internal m 6 A and m 7 G RNA modifications in hematopoietic system and acute myeloid leukemia","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin. Med. J. Engl."},{"key":"B89","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40164-024-00477-8","article-title":"METTL1 mediated tRNA m(7)G modification promotes leukaemogenesis of AML via tRNA regulated translational control","volume":"13","author":"Zhao","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-018-0581-9","article-title":"A loss-of-function genetic screening reveals synergistic targeting of AKT\/mTOR and WTN\/\u03b2-catenin pathways for treatment of AML with high PRL-3 phosphatase","volume":"11","author":"Zhou","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"122949","DOI":"10.1016\/j.biomaterials.2024.122949","article-title":"Transplantation of peripheral nerve tissueoid based on a decellularized optic nerve scaffold to restore rat hindlimb sensory and movement functions","volume":"315","author":"Zhu","year":"2024","journal-title":"Biomaterials"},{"key":"B92","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41368-024-00297-w","article-title":"Phenformin activates ER stress to promote autophagic cell death via NIBAN1 and DDIT4 in oral squamous cell carcinoma independent of AMPK","volume":"16","author":"Zhuang","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.3892\/or.2016.5065","article-title":"Effect of PPM1H on malignant phenotype of human pancreatic cancer cells","volume":"36","author":"Zhu","year":"2016","journal-title":"Oncol. Rep."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1540992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T01:51:34Z","timestamp":1749779494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1540992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":93,"alternative-id":["10.3389\/fgene.2025.1540992"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1540992","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"article-number":"1540992"}}